Bausch and Lomb | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

386,798 results for “Bausch and Lomb”

FDA Warns Bausch + Lomb and Indian API Maker for GMP Issues

Bausch + Lomb Recalls enVista Intraocular Lenses Due to Inflammatory Complications

Miebo and Xdemvy Show Strong First-Year Performance in Treating Dry Eye Disease and Demodex Blepharitis

Advancements in Retina and Vitreous Treatments Highlighted in Recent Studies and Collaborations

Pantheon Vision Pioneers Bioengineered Solutions to Combat Global Corneal Blindness

Nicox Secures $16.5 Million Financing to Advance NCX 470 Glaucoma Trial

Bausch & Lomb's Miebo Costs 40 Times More Than European Equivalent, Highlighting Regulatory Pricing Loopholes

Bausch + Lomb Acquires Whitecap Biosciences to Expand Ophthalmology Pipeline

AbbVie Advances Two Clinical Trials: Icalcaprant for Depression and ABBV-444 for Dry Eye Disease

China's NMPA Accepts NCX 470 NDA for Review in Open-Angle Glaucoma and Ocular Hypertension

Page 1 of 4098